* IRadimed Corp IRMD.OQ reported quarterly adjusted
earnings of
33 cents per share for the quarter ended in December. The mean
expectation of two analysts for the quarter was for earnings of
21 cents per share.
* Revenue rose 38.9% to $11.87 million from a year ago;
analysts
expected $11.63 million.
* IRadimed Corp's reported EPS for the quarter was 31
cents.
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* IRadimed Corp shares had fallen by 15.0% this quarter.
* The company reported quarterly net income of $3.89
million.
* Wall Street's median 12-month price target for IRadimed
Corp is
$41.00
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
This summary was machine generated February 4 at 02:30 p.m.
All figures in US dollars unless otherwise stated